Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and
may be a harbinger of dementia. In view of its importance, the Movement Disorder Society …

Background A Task Force was convened by the EFNS / MDS ‐ ES Scientist Panel on P
arkinson's disease ( PD ) and other movement disorders to systemically review relevant …

… Jaime Kulisevsky contributed to the conception and execution of the research project,
wrote the first draft, and reviewed and critiqued the statistical analysis and the manuscript. Brit …

We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

Deep brain stimulation (DBS) is associated with significant improvement of motor complications
in patients with severe Parkinson's disease after some 6–12 months of treatment. Long-…

Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

This article presents the revision process, major innovations, and clinimetric testing program
for the Movement Disorder Society (MDS)–sponsored revision of the Unified Parkinson's …

Background: In studies of mild cognitive impairment (MCI) in Parkinson disease (PD), patients
without dementia have reported variable prevalences and profiles of MCI, likely to be due …

Background Cholinergic deficits are prominent in patients who have dementia associated
with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor …

… J. Kulisevsky has contributed to execution of the research project, to the review and critique
of the statistical analysis, and to the first draft of the manuscript. JA Obeso has had a major …